New Delhi: A step has been taken to prevent misuse of antibiotics Indiaof the country drug regulator has asked its state counterparts to provide the list of antibiotic combinations licensed for manufacturing and marketing in their states within two weeks.

“You are also requested to monitor the availability of any unapproved antibiotic combinations if ongoing market Take necessary action within your jurisdiction and under the provisions Drugs and Cosmetics Act and Rules and inform CDSCO (Central Drugs Standard Control Organization) on priority from time to time,” the drug regulator said in a letter state drug regulator And port officer.

ET has seen a copy of the letter dated May 16.

This step has been taken following the recommendations of sub committee The experts were formed on the orders of India’s top technical body on drugs Drug Technical Authorization Board (DTAB).

The sub-committee meeting was held on May 1.

Last year the expert committee met Indian Council of Medical Research (ICMR) is on the path to strategic access to new antibiotics and regulation against excessive irrational use of antibiotics in India.

One of the recommendations of the expert group was to take steps to immediately ban inappropriate combinations being sold in the country and ensure that such combinations do not enter the Indian markets in future.

This was followed by a meeting chaired by Directorate General of Health Services (DGHS) Atul Goyal will discuss how to regulate antibiotics Overuse and irrational use.

The committee had decided in October last year that the drug regulatory authority would be responsible for six-monthly review of various scheduled drugs drug combination Marketing of antibiotics in different states.

The proposal was made in 90 DTAB meeting It was held in January this year and a sub-committee was formed under the chairmanship of DS Arya to examine the matter in detail and give its recommendations. DGHS’s letter to state authorities is based on the recommendations of this sub-committee.